beta-lactams has been researched along with Pneumonia, Pneumococcal in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.23) | 18.7374 |
1990's | 1 (3.23) | 18.2507 |
2000's | 18 (58.06) | 29.6817 |
2010's | 9 (29.03) | 24.3611 |
2020's | 2 (6.45) | 2.80 |
Authors | Studies |
---|---|
Athlin, S; Hedlund, J; Magnuson, A; Nauclér, P; Spindler, C; Strålin, K | 1 |
Anzueto, A; Brozek, J; Cooley, LA; Crothers, K; Dean, NC; Fine, MJ; Flanders, SA; Griffin, MR; Long, AC; Metersky, ML; Metlay, JP; Musher, DM; Restrepo, MI; Waterer, GW; Whitney, CG | 1 |
Courter, J; Mortensen, JE; Murphy, ME; Powell, E | 1 |
Abat, C; Diene, SM; Raoult, D; Rolain, JM | 1 |
Bueno, L; Ceccato, A; Cilloniz, C; Ferrer, M; Gabarrus, A; Garcia-Vidal, C; Martin-Loeches, I; Niederman, MS; Ranzani, OT; Torres, A | 1 |
Bootsma, HJ; Cobbaert, CM; de Vries, JJC; Groeneveld, GH; Joosten, SA; Kuijper, EJ; van der Reyden, TJ; van Dissel, JT | 1 |
Arnold, C; Bassetti, S; Piso, RJ | 1 |
Abeysinghe, N; Batuwanthudawe, R; Dassanayake, M; de Silva, S; Karunarathne, K; Lalitha, MK; Steinhoff, M; Thomas, K | 1 |
Lynch, JP; Zhanel, GG | 1 |
Ardanuy, C; Carratalà, J; Coromines, M; Dorca, J; Fernández, A; Fernández-Serrano, S; Garcia-Vidal, C; Gudiol, F; Manresa, F; Masuet, C; Padrones, S | 1 |
Alfandari, S; Boussekey, N; Chiche, A; Devos, P; Georges, H; Leroy, O; Meybeck, A; Olive, D | 1 |
Boyd, KL; Heston, SM; Karlström, A; McCullers, JA; Tuomanen, EI | 1 |
Carbonnelle, S; De Bel, A; Dediste, A; Glupczynski, Y; Huang, TD; Jacobs, F; Jordens, P; Lismond, A; Schatt, P; Tulkens, PM; Van Bambeke, F; Verhaegen, J; Verschuren, F | 1 |
Cambronero-Hernandez, E; Carides, A; Isaacs, R; Oliveria, T; Rohlf, J; Simon, S; Vetter, N | 1 |
Almela, M; García, E; Horcajada, JP; Marco, F; Marco, MA; Martínez, JA; Mensa, J; Soriano, A; Torres, A | 1 |
Friedland, IR; Isaacs, RD; McCarroll, KA; Woods, GL | 1 |
Holmberg, H; Sjöberg, L; Stralin, K | 1 |
Garau, J | 1 |
Allouch, P; Decousser, JW; Methlouthi, I; Pina, P | 1 |
Granizo Martínez, JJ | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Bishai, WR; Helke, K; Nuermberger, E | 1 |
Mufson, MA; Stanek, RJ | 1 |
Marco, F; Marcos, A; Mensa, JM; Pinart, M; Piñer, R; Torres, A; Vallès, X | 1 |
Harbarth, S; Nobre, V; Pittet, D | 1 |
Bliziotis, IA; Falagas, ME; Panos, GZ; Siempos, II | 1 |
Arroyo, L; Obando, I; Sanchez-Tatay, D | 1 |
Bast, DJ; De Azavedo, JC; Dresser, L; Duncan, CL; Low, DE; Walker, SE | 1 |
Kienitz, M | 1 |
Abe, T; Domon, H; Fukuoka, T; Ishii, C; Kakuta, M; Kawada, H; Kitayama, A; Ohya, S; Utsui, Y | 1 |
File, TM | 1 |
5 review(s) available for beta-lactams and Pneumonia, Pneumococcal
Article | Year |
---|---|
Streptococcus pneumoniae: does antimicrobial resistance matter?
Topics: Anti-Bacterial Agents; beta-Lactams; California; Canada; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Evidence-Based Medicine; Humans; Penicillin Resistance; Penicillins; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Prevalence; Risk Assessment; Risk Factors; Streptococcal Infections; Streptococcus pneumoniae | 2009 |
Role of beta-lactam agents in the treatment of community-acquired pneumonia.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Community-Acquired Infections; Haemophilus influenzae; Humans; Infant; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Outcome | 2005 |
Does antibiotic selection impact patient outcome?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Pneumococcal; Prognosis; Sepsis; Survival Rate | 2007 |
Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Humans; Outcome Assessment, Health Care; Pneumonia, Pneumococcal; Prospective Studies; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae.
Topics: beta-Lactam Resistance; beta-Lactams; Contraindications; Humans; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Streptococcus pneumoniae | 2002 |
3 trial(s) available for beta-lactams and Pneumonia, Pneumococcal
Article | Year |
---|---|
Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Female; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Netherlands; Plasma; Pneumonia, Pneumococcal; Rifampin; Teichoic Acids; Treatment Outcome; Young Adult | 2019 |
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Europe; Female; Hospitalization; Humans; Injections, Intramuscular; Injections, Intravenous; Lactams; Latin America; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
Ertapenem therapy for community-acquired pneumonia in the elderly.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Logistic Models; Male; Odds Ratio; Pneumonia, Pneumococcal; Retrospective Studies; Statistics, Nonparametric; Streptococcus pneumoniae; Treatment Outcome | 2003 |
23 other study(ies) available for beta-lactams and Pneumonia, Pneumococcal
Article | Year |
---|---|
Pneumococcal urinary antigen testing for antimicrobial guidance in community-acquired pneumonia-A register-based cohort study.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Cohort Studies; Community-Acquired Infections; Humans; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae | 2022 |
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Blood Culture; Chlamydophila Infections; Community-Acquired Infections; Culture Techniques; Drug Therapy, Combination; Haemophilus Infections; Hospitalization; Humans; Legionellosis; Macrolides; Moraxellaceae Infections; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Radiography, Thoracic; Severity of Illness Index; Sputum; United States | 2019 |
Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2021 |
How artificial is the antibiotic resistance definition?
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Industry; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Politics; Practice Guidelines as Topic; Streptococcus pneumoniae; Terminology as Topic | 2017 |
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cause of Death; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Length of Stay; Macrolides; Male; Middle Aged; Pneumonia, Pneumococcal; Propensity Score; Prospective Studies; Spain; Sputum; Streptococcus pneumoniae; Survival Rate | 2019 |
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index | 2013 |
Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Blood; Cerebrospinal Fluid; Child, Hospitalized; Child, Preschool; Hospitals; Humans; Incidence; Infant; Latex Fixation Tests; Meningitis, Pneumococcal; Pneumococcal Infections; Pneumonia, Pneumococcal; Serotyping; Sri Lanka; Streptococcus pneumoniae | 2009 |
Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cytokines; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Prognosis; Prospective Studies; Streptococcus pneumoniae; Time Factors | 2010 |
Severe pneumococcal pneumonia: impact of new quinolones on prognosis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Prognosis; Quinolones; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2011 |
Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Female; Immunologic Factors; Lung; Macrolides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Orthomyxoviridae Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Toll-Like Receptor 2; Treatment Outcome | 2011 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; beta-Lactams; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Vaccination; Young Adult | 2012 |
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mortality; Multivariate Analysis; Pneumonia, Pneumococcal; Retrospective Studies; Treatment Outcome | 2003 |
Short-course beta-lactam treatment for community-acquired pneumonia.
Topics: beta-Lactam Resistance; beta-Lactams; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2004 |
In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
[Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides].
Topics: beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Utilization; Erythromycin; Humans; Macrolides; Penicillin Resistance; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Spain; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2005 |
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Respiratory Tract Infections; Streptococcus pneumoniae | 2005 |
Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy.
Topics: Aerosols; Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Drug Resistance, Bacterial; Ertapenem; Female; Mice; Mice, Inbred CBA; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Humans; Macrolides; Middle Aged; Pneumonia, Pneumococcal | 2006 |
Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Disease Susceptibility; Drug Resistance, Bacterial; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Macrolides; Male; Middle Aged; Pneumonia, Pneumococcal; Prognosis; Prospective Studies; Risk Factors; Spain; Streptococcus pneumoniae; Survival Analysis | 2006 |
Decrease in drug resistance in pneumococcal community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2007 |
Antipneumococcal activity of ertapenem compared with gatifloxacin in a temperature-sensitive murine model of acute pneumonia.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; DNA Topoisomerase IV; Ertapenem; Fluoroquinolones; Gatifloxacin; Mice; Mice, Inbred Strains; Mutation; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Temperature; Treatment Outcome | 2007 |
[Importance and administration of beta-lactam antibiotics in practice].
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ear Diseases; Humans; Pharyngitis; Pneumonia, Pneumococcal; Urinary Tract Infections | 1982 |
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Lactams; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Prodrugs; Streptococcus pneumoniae | 1999 |